<VariationArchive VariationID="426927" VariationName="NM_015338.6(ASXL1):c.1934dup (p.Gly646fs)" VariationType="Duplication" Accession="VCV000426927" Version="16" RecordType="classified" NumberOfSubmissions="11" NumberOfSubmitters="10" DateLastUpdated="2024-06-30" DateCreated="2017-05-22" MostRecentSubmission="2024-06-29">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="415680" VariationID="426927">
      <GeneList>
        <Gene Symbol="ASXL1" FullName="ASXL transcriptional regulator 1" GeneID="171023" HGNC_ID="HGNC:18318" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>20q11.21</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="32358331" stop="32439319" display_start="32358331" display_stop="32439319" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="30946146" stop="31027121" display_start="30946146" display_stop="31027121" Strand="+" />
          </Location>
          <OMIM>612990</OMIM>
          <Haploinsufficiency last_evaluated="2013-03-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL1">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-03-14" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=ASXL1">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_015338.6(ASXL1):c.1934dup (p.Gly646fs)</Name>
      <CanonicalSPDI>NC_000020.11:32434638:GGGGGGGG:GGGGGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>20q11.21</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="20" Accession="NC_000020.11" start="32434638" stop="32434639" display_start="32434638" display_stop="32434639" variantLength="1" positionVCF="32434638" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="20" Accession="NC_000020.10" start="31022441" stop="31022442" display_start="31022441" display_stop="31022442" variantLength="1" positionVCF="31022441" referenceAlleleVCF="A" alternateAlleleVCF="AG" />
      </Location>
      <ProteinChange>G585fs</ProteinChange>
      <ProteinChange>G646fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.10" sequenceAccession="NC_000020" sequenceVersion="10" change="g.31022449dup" Assembly="GRCh37">
            <Expression>NC_000020.10:g.31022449dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000020.11" sequenceAccession="NC_000020" sequenceVersion="11" change="g.32434646dup" Assembly="GRCh38">
            <Expression>NC_000020.11:g.32434646dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_027868.1" sequenceAccession="NG_027868" sequenceVersion="1" change="g.81303dup">
            <Expression>NG_027868.1:g.81303dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001363734.1" sequenceAccession="NM_001363734" sequenceVersion="1" change="c.1751dup">
            <Expression>NM_001363734.1:c.1751dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001350663.1" sequenceAccession="NP_001350663" sequenceVersion="1" change="p.Gly585fs">
            <Expression>NP_001350663.1:p.Gly585fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015338.6" sequenceAccession="NM_015338" sequenceVersion="6" change="c.1934dup" MANESelect="true">
            <Expression>NM_015338.6:c.1934dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_056153.2" sequenceAccession="NP_056153" sequenceVersion="2" change="p.Gly646fs">
            <Expression>NP_056153.2:p.Gly646fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_630t1" sequenceAccession="LRG_630t1" change="c.1934dup">
            <Expression>LRG_630t1:c.1934dup</Expression>
          </NucleotideExpression>
          <ProteinExpression>
            <Expression>LRG_630p1:p.Gly646fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015338.5" sequenceAccession="NM_015338" sequenceVersion="5" change="c.1934dupG">
            <Expression>NM_015338.5:c.1934dupG</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_630" sequenceAccession="LRG_630">
            <Expression>LRG_630:g.81303dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_015338.6" sequenceAccession="NM_015338" sequenceVersion="6" change="c.1934dupG" MANESelect="true">
            <Expression>NM_015338.6:c.1934dupG</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA9808490" DB="ClinGen" />
        <XRef Type="rs" ID="750318549" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_015338.6(ASXL1):c.1934dup (p.Gly646fs) AND not provided" Accession="RCV000489373" Version="6">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2023-12-23" SubmissionCount="3">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015338.6(ASXL1):c.1934dup (p.Gly646fs) AND Bohring-Opitz syndrome" Accession="RCV000677687" Version="13">
        <ClassifiedConditionList TraitSetID="1273">
          <ClassifiedCondition DB="MedGen" ID="C0796232">Bohring-Opitz syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
            <Description DateLastEvaluated="2024-03-25" SubmissionCount="7">Pathogenic/Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_015338.6(ASXL1):c.1934dup (p.Gly646fs) AND Abnormal brain morphology" Accession="RCV001526628" Version="2">
        <ClassifiedConditionList TraitSetID="24361">
          <ClassifiedCondition DB="MedGen" ID="C4021085">Abnormal brain morphology</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Likely pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2024-03-25" NumberOfSubmissions="11" NumberOfSubmitters="10" DateCreated="2017-05-22" MostRecentSubmission="2024-06-29">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic/Likely pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20880116</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21576631</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">21881046</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22031865</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22058207</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">22489043</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23018865</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23619563</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23690417</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24255920</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24442206</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24458439</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24496303</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">24695057</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25596267</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">25652455</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27276561</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">27895058</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">29681105</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">30147881</ID>
        </Citation>
        <DescriptionHistory Dated="2018-09-03">
          <Description>Pathogenic</Description>
        </DescriptionHistory>
        <DescriptionHistory Dated="2018-09-03">
          <Description>Likely pathogenic</Description>
        </DescriptionHistory>
        <ConditionList>
          <TraitSet ID="1273" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="1074" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Opitz trigonocephaly-like syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Bohring-Opitz syndrome</ElementValue>
                <XRef ID="MONDO:0011510" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Bohring syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">BOS syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">C-like syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">BOPS</ElementValue>
                <XRef Type="MIM" ID="605039" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10140" />
                <XRef ID="10140" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Bohring-Opitz syndrome (BOS) is characterized by distinctive facial features and posture, growth failure, variable but usually severe intellectual disability, and variable anomalies. The facial features may include microcephaly or trigonocephaly / prominent (but not fused) metopic ridge, hypotonic facies with full cheeks, synophrys, glabellar and eyelid nevus flammeus (simplex), prominent globes, widely set eyes, palate anomalies, and micrognathia. The BOS posture, which is most striking in early childhood and often becomes less apparent with age, is characterized by flexion at the elbows with ulnar deviation and flexion of the wrists and metacarpophalangeal joints. Feeding difficulties in early childhood, including cyclic vomiting, have a significant impact on overall health; feeding tends to improve with age. Seizures are common and typically responsive to standard epileptic medications. Minor cardiac anomalies and transient bradycardia and apnea may be present. Affected individuals may experience recurrent infections, which also tend to improve with age. Isolated case reports suggest that individuals with BOS are at greater risk for Wilms tumor than the general population, but large-scale epidemiologic studies have not been conducted.</Attribute>
                <XRef ID="NBK481833" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">29446906</ID>
                <ID Source="BookShelf">NBK481833</ID>
              </Citation>
              <XRef ID="97297" DB="Orphanet" />
              <XRef ID="C0796232" DB="MedGen" />
              <XRef ID="MONDO:0011510" DB="MONDO" />
              <XRef Type="MIM" ID="605039" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="24361" Type="Finding" ContributesToAggregateClassification="true">
            <Trait ID="30325" Type="Finding">
              <Name>
                <ElementValue Type="Alternate">Abnormality of brain morphology</ElementValue>
                <XRef ID="HP:0012443" DB="Human Phenotype Ontology" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Abnormal brain morphology</ElementValue>
                <XRef ID="HP:0012443" DB="Human Phenotype Ontology" />
              </Name>
              <XRef ID="C4021085" DB="MedGen" />
              <XRef Type="primary" ID="HP:0012443" DB="Human Phenotype Ontology" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3001762" SubmissionDate="2021-03-05" DateLastUpdated="2021-03-22" DateCreated="2021-03-22">
        <ClinVarSubmissionID localKey="NM_015338.5:c.1934dupG|OMIM:605039" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001526547" DateUpdated="2021-03-22" DateCreated="2021-03-22" Type="SCV" Version="1" SubmitterName="Baylor Genetics" OrgID="1006" OrganizationCategory="laboratory" OrgAbbreviation="BCM: BMGL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2018-08-22">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was determined to be pathogenic according to ACMG Guidelines, 2015 [PMID:25741868].</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015338.5:c.1934dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605039" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9201740</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3414362" SubmissionDate="2021-06-14" DateLastUpdated="2021-06-19" DateCreated="2021-06-19">
        <ClinVarSubmissionID localKey="PED8912.1|HPO:HP:0012443" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001737058" DateUpdated="2021-06-19" DateCreated="2021-06-19" Type="SCV" Version="1" SubmitterName="Equipe Genetique des Anomalies du Developpement, Université de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">LRG_630t1:c.1934dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="HP" ID="HP:0012443" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9847331</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3800016" SubmissionDate="2021-09-23" DateLastUpdated="2021-09-26" DateCreated="2021-09-26">
        <ClinVarSubmissionID localKey="CVb_288|OMIM:605039" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001934374" DateUpdated="2021-09-26" DateCreated="2021-09-26" Type="SCV" Version="1" SubmitterName="Institute of Human Genetics, University of Leipzig Medical Center" OrgID="506086" OrganizationCategory="clinic" OrgAbbreviation="UKL" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-12-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant was identified as de novo (maternity and paternity confirmed).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015338.6:c.1934dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605039" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB10413949</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1123746" SubmissionDate="2021-09-25" DateLastUpdated="2017-05-22" DateCreated="2017-05-22">
        <ClinVarSubmissionID localKey="GDXSV:158133" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV000577504" DateUpdated="2017-05-22" DateCreated="2017-05-22" Type="SCV" Version="4" SubmitterName="GeneDx" OrgID="26957" OrganizationCategory="laboratory" OrgAbbreviation="GDX" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-02-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Frameshift variant predicted to result in protein truncation, as the last 896 amino acids are replaced with 11 different amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (Stenson et al., 2014); This variant is associated with the following publications: (PMID: 28832022, 33502020, 32381577, 28229513, 20596031, 20693432, 30013160, 29681105, 30147881)</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">GeneDx Variant Classification Process June 2021</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/fc81e176/genedx_variant_classification_process_june_2021.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">GDX:1522197</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015338.5:c.1934dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not Provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>GeneDX_Clinvar_Submission_51_20210925044204</SubmissionName>
          <SubmissionName>SUB5098196</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5468877" SubmissionDate="2022-12-30" DateLastUpdated="2022-12-31" DateCreated="2022-12-31">
        <ClinVarSubmissionID localKey="A18688|not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV002817241" DateUpdated="2022-12-31" DateCreated="2022-12-31" Type="SCV" Version="1" SubmitterName="Athena Diagnostics" OrgID="1012" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-05-27">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant causes a frameshift at codon 646 which results in the creation of a premature stop codon and the loss of 896 amino acids. Multiple truncating variants in this region have been reported in patients with Bohring-Opitz syndrome (PMID: 21706002, 28229513). This variant has been confirmed to occur de novo in multiple individuals with clinical features associated with this gene (PMID: 29681105, 30147881). This variant has been observed in the general population at a frequency higher than expected for a pathogenic variant in this gene. However, this frequency may represent acquired somatic mosaicism which has been reported to occur with age during hematopoietic clonal expansion of cells with pathogenic ASXL1 variants in healthy individuals. (https://gnomad.broadinstitute.org/, PMID 28229513)This observation is not an independent occurrence and has been identified in the same individual by RCIGM, the other laboratory participating in the GEMINI study.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Athena Diagnostics Criteria</Attribute>
          <Citation>
            <ID Source="PubMed">26467025</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015338.6:c.1934dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12495508</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7113213" SubmissionDate="2023-03-01" DateLastUpdated="2023-03-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="c41515e93670c1660ac4e9ae5f211a44" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV003807114" DateUpdated="2023-03-04" DateCreated="2023-03-04" Type="SCV" Version="1" SubmitterName="Laboratorio de Genetica e Diagnostico Molecular, Hospital Israelita Albert Einstein" OrgID="508506" OrganizationCategory="laboratory" OrgAbbreviation="LABO-HIAE" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-06-14">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>ACMG classification criteria: PVS1 very strong, PS4 supporting, PM2 moderated, PM6 strong</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <GeographicOrigin>Brazil</GeographicOrigin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <NumberTested>1</NumberTested>
            </Sample>
            <Method>
              <Description>Paired-end whole-genome sequencing</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015338.6:c.1934dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605039" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12925816</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="1567405" SubmissionDate="2023-02-24" DateLastUpdated="2023-03-26" DateCreated="2018-08-25">
        <ClinVarSubmissionID localKey="PED8912.1|OMIM:605039" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000803831" DateUpdated="2023-03-26" DateCreated="2018-08-25" Type="SCV" Version="2" SubmitterName="Equipe Genetique des Anomalies du Developpement, Université de Bourgogne" OrgID="506039" OrganizationCategory="laboratory" OrgAbbreviation="GADteam" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2021-03-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Likely pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <TypePlatform>Next-gen. Sequencing</TypePlatform>
              <Description>Exome sequencing</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">LRG_630t1:c.1934dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605039" Type="MIM" />
          </Trait>
        </TraitSet>
        <StudyName>Clinvar_gadteam_Clinical_exome_analysis_3</StudyName>
        <StudyDescription>Class 4-5 variants (ACMG) identified by pangenomic NGS assays in GAD laboratory, Dijon, France</StudyDescription>
        <SubmissionNameList>
          <SubmissionName>Clinvar_gadteam_Clinical_exome_analysis_3</SubmissionName>
          <SubmissionName>SUB12873630</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7682740" SubmissionDate="2023-11-13" DateLastUpdated="2023-11-20" DateCreated="2023-11-20">
        <ClinVarSubmissionID localKey="MAC S6|OMIM:605039" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004102730" DateUpdated="2023-11-20" DateCreated="2023-11-20" Type="SCV" Version="1" SubmitterName="Daryl Scott Lab, Baylor College of Medicine" OrgID="505993" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-11-10">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015338.5:c.1934dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605039" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13969089</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="7121769" SubmissionDate="2024-01-26" DateLastUpdated="2024-02-04" DateCreated="2023-03-04">
        <ClinVarSubmissionID localKey="74d35a33e05134fd53111cc530742c0d319565683041e772cb5b3eac7c53acd2|OMIM:605039" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003811056" DateUpdated="2024-02-04" DateCreated="2023-03-04" Type="SCV" Version="2" SubmitterName="Revvity Omics, Revvity" OrgID="167595" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-03">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015338.6:c.1934dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="605039" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12922107</SubmissionName>
          <SubmissionName>SUB14173319</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5977882" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="3404274|MedGen:CN517202" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003288802" DateUpdated="2024-02-14" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-23">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">29681105</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30147881</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Gly646Trpfs*12) in the ASXL1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 896 amino acid(s) of the ASXL1 protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with Bohring-Opitz syndrome (PMID: 29681105, 30147881). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 426927). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000020.10:g.31022441_31022442insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="CN517202" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="4891176" SubmissionDate="2024-06-28" DateLastUpdated="2024-06-29" DateCreated="2022-04-23">
        <ClinVarSubmissionID localKey="NM_015338.6:c.1934dupG|MedGen:C0796232" />
        <ClinVarAccession Accession="SCV002500552" DateUpdated="2024-06-29" DateCreated="2022-04-23" Type="SCV" Version="4" SubmitterName="Women's Health and Genetics/Laboratory Corporation of America, LabCorp" OrgID="500026" OrganizationCategory="laboratory" OrgAbbreviation="WHG-LC" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2024-03-25">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">22489043</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24442206</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24458439</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25652455</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24695057</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23018865</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21881046</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23619563</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">20880116</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23690417</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22031865</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">25596267</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">22058207</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24496303</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">21576631</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">24255920</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27895058</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">27276561</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">29681105</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">30147881</ID>
          </Citation>
          <Comment>Variant summary: ASXL1 c.1934dupG (p.Gly646TrpfsX12) located in the last exon results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been reported in association with Bohring-Opitz syndrome in the HGMD/LOVD databases. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. c.1934dupG has been reported in the literature as a de-novo variant in at-least two individuals affected with Bohring-Opitz Syndrome (example, Kibe_2017, Urreizti_2018). As this variant is located in a homopolymer tract of guanines it is prone to replication slippage and could be overrepresented as sequencing artifacts. This variant has also been reported to be a common cancer-associated ASXL1 variant in settings of myeloid malignancies (Van Ness_2016). These data indicate that the variant may be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. ClinVar contains an entry for this variant (Variation ID: 426927). Based on the evidence outlined above, in settings where somatic mosaicism, clonal hematopoiesis of indeterminate potential (CHIP) and technical artifacts of analysis are ruled out, the variant was classified as pathogenic in association with Bohring-Opitz Syndrome.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">LabCorp Variant Classification Summary - May 2015</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/ft/byid/rtxspsnt/labcorp_variant_classification_method_-_may_2015.pdf</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="ASXL1" />
          </GeneList>
          <VariantType>Duplication</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_015338.6:c.1934dupG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0796232" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11350627</SubmissionName>
          <SubmissionName>clinvar-submission.2024-03.csv</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7121769" TraitType="Disease" MappingType="XRef" MappingValue="605039" MappingRef="OMIM">
        <MedGen CUI="C0796232" Name="Bohring-Opitz syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7113213" TraitType="Disease" MappingType="XRef" MappingValue="605039" MappingRef="OMIM">
        <MedGen CUI="C0796232" Name="Bohring-Opitz syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3800016" TraitType="Disease" MappingType="XRef" MappingValue="605039" MappingRef="OMIM">
        <MedGen CUI="C0796232" Name="Bohring-Opitz syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3001762" TraitType="Disease" MappingType="XRef" MappingValue="605039" MappingRef="OMIM">
        <MedGen CUI="C0796232" Name="Bohring-Opitz syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5468877" TraitType="Disease" MappingType="Name" MappingValue="not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3414362" TraitType="Finding" MappingType="XRef" MappingValue="HP:0012443" MappingRef="HP">
        <MedGen CUI="C4021085" Name="Abnormal brain morphology" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1123746" TraitType="Disease" MappingType="Name" MappingValue="Not Provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="7682740" TraitType="Disease" MappingType="XRef" MappingValue="605039" MappingRef="OMIM">
        <MedGen CUI="C0796232" Name="Bohring-Opitz syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="4891176" TraitType="Disease" MappingType="XRef" MappingValue="C0796232" MappingRef="MedGen">
        <MedGen CUI="C0796232" Name="Bohring-Opitz syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="1567405" TraitType="Disease" MappingType="XRef" MappingValue="605039" MappingRef="OMIM">
        <MedGen CUI="C0796232" Name="Bohring-Opitz syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5977882" TraitType="Disease" MappingType="XRef" MappingValue="CN517202" MappingRef="MedGen">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

